Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

HWKN vs CBT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HWKN
Hawkins, Inc.

Chemicals - Specialty

Basic MaterialsNASDAQ • US
Market Cap$3.46B
5Y Perf.+678.6%
CBT
Cabot Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$4.24B
5Y Perf.+127.5%

HWKN vs CBT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HWKN logoHWKN
CBT logoCBT
IndustryChemicals - SpecialtyChemicals - Specialty
Market Cap$3.46B$4.24B
Revenue (TTM)$1.06B$3.58B
Net Income (TTM)$82M$285M
Gross Margin22.9%24.8%
Operating Margin11.5%15.7%
Forward P/E42.3x13.0x
Total Debt$160M$1.22B
Cash & Equiv.$5M$258M

HWKN vs CBTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HWKN
CBT
StockMay 20May 26Return
Hawkins, Inc. (HWKN)100778.6+678.6%
Cabot Corporation (CBT)100227.5+127.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: HWKN vs CBT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HWKN leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and dividend income and shareholder returns. Cabot Corporation is the stronger pick specifically for valuation and capital efficiency and profitability and margin quality. As sector peers, any of these can serve as alternatives in the same allocation.
HWKN
Hawkins, Inc.
The Growth Play

HWKN carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 6.0%, EPS growth 12.3%, 3Y rev CAGR 8.0%
  • 7.7% 10Y total return vs CBT's 115.7%
  • Lower volatility, beta 0.98, Low D/E 34.7%, current ratio 2.15x
Best for: growth exposure and long-term compounding
CBT
Cabot Corporation
The Income Pick

CBT is the clearest fit if your priority is income & stability and defensive.

  • Dividend streak 4 yrs, beta 0.78, yield 2.2%
  • Beta 0.78, yield 2.2%, current ratio 1.61x
  • Lower P/E (13.0x vs 42.3x)
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthHWKN logoHWKN6.0% revenue growth vs CBT's -7.0%
ValueCBT logoCBTLower P/E (13.0x vs 42.3x)
Quality / MarginsCBT logoCBT8.0% margin vs HWKN's 7.8%
Stability / SafetyCBT logoCBTBeta 0.78 vs HWKN's 0.98
DividendsHWKN logoHWKN0.4% yield, 5-year raise streak, vs CBT's 2.2%
Momentum (1Y)HWKN logoHWKN+40.6% vs CBT's +13.8%
Efficiency (ROA)HWKN logoHWKN8.4% ROA vs CBT's 7.4%, ROIC 15.9% vs 17.4%

HWKN vs CBT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HWKNHawkins, Inc.
FY 2025
Bulk
88.0%$96M
Other
12.0%$13M
CBTCabot Corporation
FY 2025
Reinforcement Materials
65.2%$2.3B
Performance Chemicals
34.8%$1.3B

HWKN vs CBT — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCBTLAGGINGHWKN

Income & Cash Flow (Last 12 Months)

CBT leads this category, winning 4 of 6 comparable metrics.

CBT is the larger business by revenue, generating $3.6B annually — 3.4x HWKN's $1.1B. Profitability is closely matched — net margins range from 8.0% (CBT) to 7.8% (HWKN). On growth, HWKN holds the edge at +7.9% YoY revenue growth, suggesting stronger near-term business momentum.

MetricHWKN logoHWKNHawkins, Inc.CBT logoCBTCabot Corporation
RevenueTrailing 12 months$1.1B$3.6B
EBITDAEarnings before interest/tax$172M$731M
Net IncomeAfter-tax profit$82M$285M
Free Cash FlowCash after capex$88M$459M
Gross MarginGross profit ÷ Revenue+22.9%+24.8%
Operating MarginEBIT ÷ Revenue+11.5%+15.7%
Net MarginNet income ÷ Revenue+7.8%+8.0%
FCF MarginFCF ÷ Revenue+8.2%+12.8%
Rev. Growth (YoY)Latest quarter vs prior year+7.9%-3.4%
EPS Growth (YoY)Latest quarter vs prior year-4.2%-23.1%
CBT leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

CBT leads this category, winning 6 of 6 comparable metrics.

At 13.5x trailing earnings, CBT trades at a 67% valuation discount to HWKN's 41.4x P/E. On an enterprise value basis, CBT's 6.7x EV/EBITDA is more attractive than HWKN's 22.7x.

MetricHWKN logoHWKNHawkins, Inc.CBT logoCBTCabot Corporation
Market CapShares × price$3.5B$4.2B
Enterprise ValueMkt cap + debt − cash$3.6B$5.2B
Trailing P/EPrice ÷ TTM EPS41.44x13.50x
Forward P/EPrice ÷ next-FY EPS est.42.31x13.04x
PEG RatioP/E ÷ EPS growth rate1.67x
EV / EBITDAEnterprise value multiple22.74x6.71x
Price / SalesMarket cap ÷ Revenue3.55x1.14x
Price / BookPrice ÷ Book value/share7.60x2.58x
Price / FCFMarket cap ÷ FCF49.48x10.86x
CBT leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

Evenly matched — HWKN and CBT each lead in 4 of 8 comparable metrics.

CBT delivers a 16.8% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $16 for HWKN. HWKN carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to CBT's 0.71x.

MetricHWKN logoHWKNHawkins, Inc.CBT logoCBTCabot Corporation
ROE (TTM)Return on equity+15.9%+16.8%
ROA (TTM)Return on assets+8.4%+7.4%
ROICReturn on invested capital+15.9%+17.4%
ROCEReturn on capital employed+19.3%+21.3%
Piotroski ScoreFundamental quality 0–966
Debt / EquityFinancial leverage0.35x0.71x
Net DebtTotal debt minus cash$155M$957M
Cash & Equiv.Liquid assets$5M$258M
Total DebtShort + long-term debt$160M$1.2B
Interest CoverageEBIT ÷ Interest expense10.27x14.72x
Evenly matched — HWKN and CBT each lead in 4 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

HWKN leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in HWKN five years ago would be worth $49,115 today (with dividends reinvested), compared to $14,321 for CBT. Over the past 12 months, HWKN leads with a +40.6% total return vs CBT's +13.8%. The 3-year compound annual growth rate (CAGR) favors HWKN at 61.2% vs CBT's 7.0% — a key indicator of consistent wealth creation.

MetricHWKN logoHWKNHawkins, Inc.CBT logoCBTCabot Corporation
YTD ReturnYear-to-date+15.1%+21.9%
1-Year ReturnPast 12 months+40.6%+13.8%
3-Year ReturnCumulative with dividends+318.9%+22.5%
5-Year ReturnCumulative with dividends+391.1%+43.2%
10-Year ReturnCumulative with dividends+765.9%+115.7%
CAGR (3Y)Annualised 3-year return+61.2%+7.0%
HWKN leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

CBT leads this category, winning 2 of 2 comparable metrics.

CBT is the less volatile stock with a 0.78 beta — it tends to amplify market swings less than HWKN's 0.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBT currently trades 96.1% from its 52-week high vs HWKN's 89.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricHWKN logoHWKNHawkins, Inc.CBT logoCBTCabot Corporation
Beta (5Y)Sensitivity to S&P 5000.98x0.78x
52-Week HighHighest price in past year$186.15$84.60
52-Week LowLowest price in past year$115.35$58.33
% of 52W HighCurrent price vs 52-week peak+89.7%+96.1%
RSI (14)Momentum oscillator 0–10062.971.7
Avg Volume (50D)Average daily shares traded169K374K
CBT leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — HWKN and CBT each lead in 1 of 2 comparable metrics.

Wall Street rates HWKN as "Buy" and CBT as "Buy". For income investors, CBT offers the higher dividend yield at 2.18% vs HWKN's 0.42%.

MetricHWKN logoHWKNHawkins, Inc.CBT logoCBTCabot Corporation
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$78.00
# AnalystsCovering analysts115
Dividend YieldAnnual dividend ÷ price+0.4%+2.2%
Dividend StreakConsecutive years of raises54
Dividend / ShareAnnual DPS$0.70$1.77
Buyback YieldShare repurchases ÷ mkt cap+0.7%+4.0%
Evenly matched — HWKN and CBT each lead in 1 of 2 comparable metrics.
Key Takeaway

CBT leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). HWKN leads in 1 (Total Returns). 2 tied.

Best OverallCabot Corporation (CBT)Leads 3 of 6 categories
Loading custom metrics...

HWKN vs CBT: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is HWKN or CBT a better buy right now?

For growth investors, Hawkins, Inc.

(HWKN) is the stronger pick with 6. 0% revenue growth year-over-year, versus -7. 0% for Cabot Corporation (CBT). Cabot Corporation (CBT) offers the better valuation at 13. 5x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Hawkins, Inc. (HWKN) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HWKN or CBT?

On trailing P/E, Cabot Corporation (CBT) is the cheapest at 13.

5x versus Hawkins, Inc. at 41. 4x. On forward P/E, Cabot Corporation is actually cheaper at 13. 0x.

03

Which is the better long-term investment — HWKN or CBT?

Over the past 5 years, Hawkins, Inc.

(HWKN) delivered a total return of +391. 1%, compared to +43. 2% for Cabot Corporation (CBT). Over 10 years, the gap is even starker: HWKN returned +765. 9% versus CBT's +115. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HWKN or CBT?

By beta (market sensitivity over 5 years), Cabot Corporation (CBT) is the lower-risk stock at 0.

78β versus Hawkins, Inc. 's 0. 98β — meaning HWKN is approximately 25% more volatile than CBT relative to the S&P 500. On balance sheet safety, Hawkins, Inc. (HWKN) carries a lower debt/equity ratio of 35% versus 71% for Cabot Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — HWKN or CBT?

By revenue growth (latest reported year), Hawkins, Inc.

(HWKN) is pulling ahead at 6. 0% versus -7. 0% for Cabot Corporation (CBT). On earnings-per-share growth, the picture is similar: Hawkins, Inc. grew EPS 12. 3% year-over-year, compared to -10. 4% for Cabot Corporation. Over a 3-year CAGR, HWKN leads at 8. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HWKN or CBT?

Cabot Corporation (CBT) is the more profitable company, earning 8.

9% net margin versus 8. 7% for Hawkins, Inc. — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBT leads at 16. 7% versus 12. 2% for HWKN. At the gross margin level — before operating expenses — CBT leads at 25. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HWKN or CBT more undervalued right now?

On forward earnings alone, Cabot Corporation (CBT) trades at 13.

0x forward P/E versus 42. 3x for Hawkins, Inc. — 29. 3x cheaper on a one-year earnings basis.

08

Which pays a better dividend — HWKN or CBT?

All stocks in this comparison pay dividends.

Cabot Corporation (CBT) offers the highest yield at 2. 2%, versus 0. 4% for Hawkins, Inc. (HWKN).

09

Is HWKN or CBT better for a retirement portfolio?

For long-horizon retirement investors, Cabot Corporation (CBT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

78), 2. 2% yield, +115. 7% 10Y return). Both have compounded well over 10 years (CBT: +115. 7%, HWKN: +765. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HWKN and CBT?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: HWKN is a small-cap quality compounder stock; CBT is a small-cap deep-value stock. CBT pays a dividend while HWKN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

HWKN

Stable Dividend Mega-Cap

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

CBT

Income & Dividend Stock

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 0.8%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform HWKN and CBT on the metrics below

Revenue Growth>
%
(HWKN: 7.9% · CBT: -3.4%)
Net Margin>
%
(HWKN: 7.8% · CBT: 8.0%)
P/E Ratio<
x
(HWKN: 41.4x · CBT: 13.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.